Search

Your search keyword '"De Renzi, Gianluigi"' showing total 12 results
Start Over Author "De Renzi, Gianluigi"
12 results on '"De Renzi, Gianluigi"'

1. Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors

Author

Magri, Valentina, primary, De Renzi, Gianluigi, additional, Marino, Luca, additional, De Meo, Michela, additional, Siringo, Marco, additional, Gelibter, Alain, additional, Gareri, Roberta, additional, Cataldi, Chiara, additional, Giannini, Giuseppe, additional, Santini, Daniele, additional, Nicolazzo, Chiara, additional, and Gazzaniga, Paola, additional

Published
2024
Full Text
View/download PDF

4. Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer

Author

Nicolazzo, Chiara, primary, Magri, Valentina, additional, Marino, Luca, additional, Belardinilli, Francesca, additional, Di Nicolantonio, Federica, additional, De Renzi, Gianluigi, additional, Caponnetto, Salvatore, additional, De Meo, Michela, additional, Giannini, Giuseppe, additional, Santini, Daniele, additional, Cortesi, Enrico, additional, and Gazzaniga, Paola, additional

Published
2023
Full Text
View/download PDF

5. RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study

Author

Nicolazzo, Chiara, primary, Belardinilli, Francesca, additional, Vestri, Annarita, additional, Magri, Valentina, additional, De Renzi, Gianluigi, additional, De Meo, Michela, additional, Caponnetto, Salvatore, additional, Di Nicolantonio, Federica, additional, Cortesi, Enrico, additional, Giannini, Giuseppe, additional, and Gazzaniga, Paola, additional

Published
2022
Full Text
View/download PDF

8. Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments

Author

Nicolazzo, Chiara, primary, Gelibter, Alain, additional, Bottillo, Irene, additional, Belardinilli, Francesca, additional, Pisegna, Simona, additional, De Renzi, Gianluigi, additional, Marinelli, Daniele, additional, Grammatico, Paola, additional, Cortesi, Enrico, additional, Giannini, Giuseppe, additional, and Gazzaniga, Paola, additional

Published
2021
Full Text
View/download PDF

9. True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature

Author

Nicolazzo, Chiara, primary, Barault, Ludovic, additional, Caponnetto, Salvatore, additional, De Renzi, Gianluigi, additional, Belardinilli, Francesca, additional, Bottillo, Irene, additional, Bargiacchi, Simone, additional, Macagno, Marco, additional, Grammatico, Paola, additional, Giannini, Giuseppe, additional, Cortesi, Enrico, additional, Di Nicolantonio, Federica, additional, and Gazzaniga, Paola, additional

Published
2021
Full Text
View/download PDF

10. Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients

Author

Nicolazzo, Chiara, primary, Barault, Ludovic, additional, Caponnetto, Salvatore, additional, Macagno, Marco, additional, De Renzi, Gianluigi, additional, Gradilone, Angela, additional, Belardinilli, Francesca, additional, Cortesi, Enrico, additional, Di Nicolantonio, Federica, additional, and Gazzaniga, Paola, additional

Published
2020
Full Text
View/download PDF

12. Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.

Author

De Renzi, Gianluigi, Gaballo, Giulio, Gazzaniga, Paola, and Nicolazzo, Chiara

Subjects
*COLON tumors, *CANCER patients, *TUMOR markers, RECTUM tumors
Abstract

According to the 2018 GLOBOCAN database, colorectal cancer is one of the most common malignancies and leading causes of cancer-related death worldwide. During the last decades, considerable progress has been made in understanding the complex pathogenetic mechanisms involved in this neoplastic disease. Due to the need to improve treatment responses and clinical outcomes of colorectal cancer patients, the identification of new molecular biomarkers became a crucial spot in clinical oncology. As biological indicators of a specific pathological or physiological process, molecular markers play a central role in cancer detection, diagnosis, outcome prediction, and treatment choice. Considering the existing evidence that malignancies originating from distinct colonic regions behave differently, it is clear that specific biomarkers can be associated to right- or left-sided colon carcinomas, reflecting the distinct molecular signatures of these different tumor entities. The aim of this review is to summarize the main differences among tumors arising from proximal and distal colon in terms of current and emerging biomarkers. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results